roger7

Jewellery was there from long time - like titan industries.. Good companies - from the list are Innova captab is a very good value buy - i worked as vendor for this company for long time-nearly 7yrs.. And one more stock to bet is Happy forgings

wait for a while.. check the trend for week.. be keen on round bottoms.. as we are heading for general elections need to be cautious.. in our investments.

hope you enjoyed the show...

BCL Industries Limited currently trading at Rs.55 per share is expected to give hefty return - with 110% return.. Mcap: 1,385 crores PE ratio: 16.5 ROCE: 14% D/E ratio: 0.88 Potential 100% gains in 12 months Promoter holdings: 60% Strong 4-year growth: 26% revenue, 30% EBITDA CAGR. Company's expanding big time for more growth and higher revenues. Cash flows sufficient to fund expansion plans.

The company's focus is changing and business base is shifting and we all know that it takes time.. Actually none of the companies has given results like natco in recent times but stock is still taking beating so.. it is not the results which will guide the stock.. in case of Laurus.. in next quarter they will roll-out their plan for sure.. on revenue guidance..

Options format is just like punting at Casino..where rules of the game keep changing that too in minutes..

wait for some more time - like another one week or so i am expecting a correction and consolidation by 7rupees or so.. but laurus is always a good stock to add-

If your are stock is good no issue.. in doing but never full-scale funds..

If Natco pharma falls to 767-775 you can add.. in long term very strong player from May'24 to June 25 I feel it will give a stupendous results.

no use sir.. grey market premium is at 65%

if it slides down.. to 203 you can make an entry.. but if you want to stand for long time then even now it is good time to enter.. i will put up my note very soon..

Congrats

https://www.moneycontrol.com/india/stockpricequote/diversified/pritiinternational/PI43 Priti International looks to be a very good stock observing it from last one week.. it has truce potential to become a multibagger.. i foresee a growth of 6X going forward..

it's good news though... lots of potential for the stock..

Rs. 383.. On 20th of Oct earnings call will be there.. i am expecting no great results - but their coverage on CDMO space+ NEXCAR future working + biosimilars trajectory will becoming pivotal points.. for future growth. but on ensuing monday scrip should see some better swing.

mention not sir, whatever I have in the form of formidable information about any company will share here...

in times to come.. i mean in an year or so this company Immunoact will become a part of Laurus Labs,but for today Laurus holds 33% stake in this company.

i have full faith on this company.. that it will hit 2500 rupees per share by 2026..

https://www.bseindia.com/xml-data/corpfiling/AttachLive/043945ed-c5e2-4555-a8c6-6b31bb8b2738.pdf

Press Release | Mumbai, October 13th, 2023 ImmunoACT announces the approval of India’s first CAR-T cell therapy, NexCAR19 (Actalycabtagene autoleucel), for the treatment of r/r B-cell lymphomas and leukemia from the Central Drugs Standard Control Organization (CDSCO). ---------------------------------------------------------------------------------------------------------------------------------------- CAR-T Cell therapy.. Immuno Act is the first company to get approval from CDSCO... The brand name is NexCAR19, wherein each treatment is valued at Rs.30lac-40lacs per sitting.. and now 27% of this company's stake... is in the hold of Laurus..

Press Release | Mumbai, October 13th, 2023 ImmunoACT announces the approval of India’s first CAR-T cell therapy, NexCAR19 (Actalycabtagene autoleucel), for the treatment of r/r B-cell lymphomas and leukemia from the Central Drugs Standard Control Organization (CDSCO).

Laurus labs filed an important update with BSE Today.